Europe — EMA

Novoseven (Eptacog Alfa (Activated))

Eptacog alfa, the active ingredient in Novoseven, is a recombinant activated factor VII presented as a sterile solution for intravenous use.

Eptacog Alfa (Activated)

Request sourcing

Pack/s

What is Eptacog Alfa (Activated)?

Eptacog alfa, the active ingredient in Novoseven, is a recombinant activated factor VII presented as a sterile solution for intravenous use. It is employed to control bleeding in patients with hemophilia A or B with inhibitors, and in acquired hemophilia. GNH USA supplies Novoseven as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Novoseven as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Eptacog Alfa (Activated) used for?

Novoseven is a recombinant activated factor VII that acts on the coagulation cascade to achieve haemostatic control.

- Hemophilia A with inhibitors: Provides rapid rapid rapid ... - Hemophilia ... ... ... ... ... ... ... ... - ... ... ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →